Orient Europharma Co Ltd (4120) — Cash Flow Quality Index
Orient Europharma Co Ltd (4120) has a Cash Flow Quality Index of 6.11x as of September 2024. Operating cash flow of NT$69.52 Million exceeds net income of NT$11.38 Million, indicating high earnings quality where cash backs reported profits. Explore Orient Europharma Co Ltd (4120) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Orient Europharma Co Ltd Cash Flow Quality Index (2015–2023)
Historical Cash Flow Quality Index for Orient Europharma Co Ltd across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see how efficiently does Orient Europharma Co Ltd generate cash.
Annual Cash Flow Quality Index for Orient Europharma Co Ltd (2015–2023)
Year-by-year earnings quality comparison for Orient Europharma Co Ltd.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 0.45x | NT$64.67 Million | NT$143.94 Million | ▼ -30.5% |
| 2021 | 0.65x | NT$77.65 Million | NT$120.17 Million | ▼ -78.8% |
| 2020 | 3.05x | NT$608.55 Million | NT$199.30 Million | ▲ +232.6% |
| 2019 | 0.92x | NT$227.37 Million | NT$247.66 Million | ▼ -2.1% |
| 2018 | 0.94x | NT$231.31 Million | NT$246.74 Million | ▼ -28.5% |
| 2017 | 1.31x | NT$601.08 Million | NT$458.73 Million | ▲ +453.2% |
| 2016 | 0.24x | NT$111.24 Million | NT$469.61 Million | ▼ -91.8% |
| 2015 | 2.89x | NT$643.97 Million | NT$223.16 Million | — |